The approval is the first new treatment advance in more than 30 years for chronic kidney disease for adults with type 1 diabetes.
News|Articles|July 12, 2004
New Product Newswire
New products from Rx to OTC
Advertisement
Advertisement
Related to this article
The approval extends the medication to a younger pediatric population, marking the first FDA-approved treatment for children with this immunodeficiency.
Advertisement
Advertisement
Trending on Drug Topics
1
Nicotine Pouches Create Opportunity for Pharmacist Counseling
2
GLP-1 Prescribing Rose Among Adults With Serious Mental Illness
3
FDA Approves Finerenone for Chronic Kidney Disease With Type 1 Diabetes
4
Worth a Shot: How ACIP Changes Might Impact Vaccine Access, Coverage
5